Our results demonstrated that the expression of TRIM6 was significantly up-regulated in Gliomas samples compared to normal tissues, suggesting that TRIM6 may be a suitable target for the development of diagnostic techniques for patients with Gliomas and may be exploited in therapeutic settings. Here, TRIM6 is linked to glioma.